Literature DB >> 26666619

A Nephrostomy-associated Urinary Tract Infection Caused by Elizabethkingia meningoseptica.

Hideharu Hagiya1, Hiroko Ogawa, Yusuke Takahashi, Kou Hasegawa, Masaya Iwamuro, Fumio Otsuka.   

Abstract

We report a case of nephrostomy-associated urinary tract infection caused by Elizabethkingia meningoseptica that occurred in a patient with retroperitoneal fibrosis. Though conventional identification methods failed to detect the causative organism, it was identified on the basis of the complete sequencing of 16S rRNA. Four weeks of levofloxacin and minocycline administration successfully eradicated the infection. E. meningoseptica rarely causes urinary tract infections, and we believe that this is the first such case in which the isolate was genetically confirmed. The accurate identification of the organism is necessary for the provision of appropriate treatment and to obtain a better understanding of its epidemiology and pathogenicity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26666619     DOI: 10.2169/internalmedicine.54.4998

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.

Authors:  Y-C Huang; Y-W Huang; Y-T Lin; F-D Wang; Y-J Chan; T-C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-07       Impact factor: 3.267

2.  Elizabethkingia meningoseptica: emerging multidrug resistance in a nosocomial pathogen.

Authors:  Sairam Raghavan; Biji Thomas; B A Shastry
Journal:  BMJ Case Rep       Date:  2017-10-10

Review 3.  Bladder Microbiome in the Context of Urological Disorders-Is There a Biomarker Potential for Interstitial Cystitis?

Authors:  Thomas Bschleipfer; Isabell Karl
Journal:  Diagnostics (Basel)       Date:  2022-01-22

4.  Does the Urinary Microbiome Play a Role in Urgency Urinary Incontinence and Its Severity?

Authors:  Lisa Karstens; Mark Asquith; Sean Davin; Patrick Stauffer; Damien Fair; W Thomas Gregory; James T Rosenbaum; Shannon K McWeeney; Rahel Nardos
Journal:  Front Cell Infect Microbiol       Date:  2016-07-27       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.